The role of neutrophils in host defense and disease
- PMID: 32283205
- PMCID: PMC8912989
- DOI: 10.1016/j.jaci.2020.02.038
The role of neutrophils in host defense and disease
Abstract
Neutrophils, the most abundant circulating leukocyte, are critical for host defense. Granulopoiesis is under the control of transcriptional factors and culminates in mature neutrophils with a broad armamentarium of antimicrobial pathways. These pathways include nicotinamide adenine dinucleotide phosphate oxidase, which generates microbicidal reactive oxidants, and nonoxidant pathways that target microbes through several mechanisms. Activated neutrophils can cause or worsen tissue injury, underscoring the need for calibration of activation and resolution of inflammation when infection has been cleared. Acquired neutrophil disorders are typically caused by cytotoxic chemotherapy or immunosuppressive agents. Primary neutrophil disorders typically result from disabling mutations of individual genes that result in impaired neutrophil number or function, and provide insight into basic mechanisms of neutrophil biology. Neutrophils can also be activated by noninfectious causes, including trauma and cellular injury, and can have off-target effects in which pathways that typically defend against infection exacerbate injury and disease. These off-target effects include acute organ injury, autoimmunity, and variable effects on the tumor microenvironment that can limit or worsen tumor progression. A greater understanding of neutrophil plasticity in these conditions is likely to pave the way to new therapeutic approaches.
Keywords: Neutrophils; degranulation; granulopoiesis; innate immunity; neutrophil dysfunction; neutrophil extracellular traps; phagocytosis.
Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure of potential conflict of interest: H. Lehman has received research contracts from Kedrion S.p.A., Leadiant Biosciences, and Takeda Ltd. B.H. Segal has served on a Data Review Committee for a Merck-sponsored clinical trial.
Figures
References
-
- Mora-Jensen H, Jendholm J, Fossum A, Porse B, Borregaard N, Theilgaard-Monch K. Technical advance: immunophenotypical characterization of human neutrophil differentiation. J Leukoc Biol 2011; 90(3): 629–34. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
